Dapagliflozin (Forxiga®) Versus Glipizide As Add-On Therapies In Type 2 Diabetes Mellitus (T2dm); An Update of The Cost-Effectiveness Based On Long-Term Clinical Evidence From Uk Nhs Perspective
Charokopou, M., Vioix, H., Verheggen, B.G., Dillon, S., Franks, D.Volume:
17
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2014.08.690
Date:
November, 2014
File:
PDF, 64 KB
english, 2014